Confirmed Control Closed Transaction verified CPG medical aesthetics Professional skincare Skin Care

Obagi Medical Products Business acquired by Haitong International Zhonghua Finance Acquisition Fund I, L.P.

Haitong International Zhonghua Finance Acquisition Fund I, L.P. acquired Obagi Medical Products Business, a skincare brand, on Nov 10, 2017.

Transaction summary

Target: Obagi Medical Products Business
Acquirer: Haitong International Zhonghua Finance Acquisition Fund I, L.P.
Seller: Valeant Pharmaceuticals
Announced: 2017-07-01
Geography: -
Tags: CPG medical aesthetics Professional skincare Skin Care
Type: Acquisition
Deal type: Control
Stake acquired: -
First added: 2026-06-15
Latest update: 2026-10-21

Value and multiples

100% enterprise value

USD 190M

100% enterprise value | USD

Basis: FundComb estimate

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

2.2x

Period not stated

Basis: FundComb estimate

EV / EBITDA

6.3x

EBITDA basis not stated

Basis: FundComb estimate

Basis

FundComb’s comps spreadsheet values the Obagi Medical Products business at USD 190m, used as the whole-company enterprise value, with revenue of USD 86m and EBITDA of USD 30m: 2.2x revenue and 6.3x EBITDA. The period is not stated. These are FundComb estimates, not confirmed by a public source. Valeant announced that it completed the sale to Haitong International Zhonghua Finance Acquisition Fund I (PR Newswire).

Source summary

Valeant Pharmaceuticals Completes Sale of Obagi Medical Products Business to Haitong International Zhongua Finance Acquisition Fund I, L.P. - PR Newswire

Confirmed

Open via Google News